COUNTERPOINT: Should BAL Be Routinely Performed in the Diagnostic Evaluation of Idiopathic Pulmonary Fibrosis? No
نویسندگان
چکیده
منابع مشابه
Antiplatelet activity should be measured routinely: no.
Antiplatelet agents such as aspirin, clopidogrel, and dipyridamole are effective in secondary stroke prevention with single agents reducing risk by 15% to 20%1–3; the addition of a second agent (eg, combining aspirin and dipyridamole) doubles this benefit.3 As with other vascular prevention strategies, eg lowering blood pressure and cholesterol, antiplatelet agents reduce, not abolish, risk. De...
متن کاملThe clinical role of BAL in idiopathic pulmonary fibrosis.
The aim of this paper is to review the literature on the clinical value of bronchoalveolar lavage (BAL) in the diagnosis and management of patients with idiopathic pulmonary fibrosis (IPF) (synonym: cryptogenic fibrosing alveolitis). This topic has been included in a number of recent detailed reviews [22-24]]. IPF is one of the most serious interstitial lung diseases. The prognosis is poor, wit...
متن کاملPirfenidone should be prescribed for patients with idiopathic pulmonary fibrosis.
Pirfenidone works. There have been four randomised placebo-control trials of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF); a phase II and phase III study in Japan, and two international multicentre phase III studies. In all four studies, patients treated with pirfenidone had slower rates of decline in lung volume (vital capacity (VC) in the Japanese studies and forced vi...
متن کاملManaging diagnostic procedures in idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis (IPF), the most prevalent of the idiopathic interstitial pneumonias, is associated with a poor prognosis. An accurate diagnosis of IPF is essential for its optimal management. The 2011 American Thoracic Society (ATS)/European Respiratory Society (ERS)/Japanese Respiratory Society (JRS)/Latin American Thoracic Association (ALAT) recommendations on the diagnosis and ...
متن کاملShould we screen for pulmonary hypertension at the initial evaluation of idiopathic pulmonary fibrosis?
a Reference Centre for Severe Pulmonary Hypertension, Department of Respiratory Medicine, AP-HP, Hôpital Bicêtre, INSERM U999, University Paris Sud, Le Kremlin-Bicêtre , b Department of Therapeutic Medicine, CHU Saint-Etienne, University of Saint-Etienne, Thrombosis Research Group, EA3065, Saint-Etienne , and c Hospices Civils de Lyon, Reference Center for Rare Pulmonary Diseases, Department of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2017
ISSN: 0012-3692
DOI: 10.1016/j.chest.2017.08.1172